Predicting nerve invasion in pancreatic cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study looks at two simple blood tests (neutrophil-to-lymphocyte ratio and CA 19.9) to see if they can predict whether the cancer has spread to nearby nerves in people with pancreatic cancer who have had surgery. This could help doctors plan better treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with pancreatic adenocarcinoma (a common type of pancreatic cancer).
- You have had surgery to remove the tumor.
- Doctors have taken blood samples before surgery (and possibly after any pre-surgery chemotherapy) to check your neutrophil/lymphocyte ratio and CA 19.9 levels.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a blood test that looks for tiny traces of cancer-related DNA (called ctDNA) in people with pancreatic cancer that can be removed with surgery. The goal is to see whether this test can better predict how the cancer behaves and guide treatment decisions around surgery.
This study looks at using a special blood test (ctDNA MRD) to track how well the tumor responds to chemotherapy before surgery for pancreatic cancer. It may help doctors decide if the treatment is working and guide next steps.
This study uses a special blood test to look for tiny amounts of cancer DNA after your pancreatic cancer surgery. It may help doctors see early if the cancer is coming back, so they can act sooner.
This study checks if a simple blood test can find tiny bits of cancer DNA after your pancreatic surgery, which may help detect if cancer comes back earlier than scans. By joining, you'll help doctors learn how to better monitor the disease and guide future treatments.
This study looks at a special analysis of your blood (called cfDNA fragmentomics) to help find and tell apart certain early pancreatic tumors. If you’re having surgery for one of the listed solid pancreatic tumors, this trial may use your blood samples to improve diagnosis.
This study uses blood tests to look at how your immune system responds, to help find pancreatic cancer earlier. It compares people with pancreatic cancer, people with benign pancreatic conditions, and healthy people to improve diagnosis.
Hear when a new Pancreatic Cancer, Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.